These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 138423)

  • 1. Possible physiological role of new peptide fragments released from bovine high molecular weight kininogen by plasma kallikrein.
    Oh-ishi S; Katori M; Nam Han Y; Iwanaga S; Kato H
    Biochem Pharmacol; 1977 Jan; 26(2):115-20. PubMed ID: 138423
    [No Abstract]   [Full Text] [Related]  

  • 2. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of a new vascular permeability enhancing peptide from kininogens by human neutrophil elastase.
    Imamura T; Tanase S; Hayashi I; Potempa J; Kozik A; Travis J
    Biochem Biophys Res Commun; 2002 Jun; 294(2):423-8. PubMed ID: 12051729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flaujeac factor deficiency. Reconstitution with highly purified bovine high molecular weight-kininogen and delineation of a new permeability-enhancing peptide released by plasma kallikrein from bovine high molecular weight-kininogen.
    Matheson RT; Miller DR; Lacombe MJ; Han YN; Iwanaga S; Kato H; wuepper KD
    J Clin Invest; 1976 Dec; 58(6):1395-406. PubMed ID: 993350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary structure of bovine plasma high-molecular-weight kininogen. Characterization of carbohydrate-free fragment 1.2 (fragment X) released by the action of plasma kallikrein and its biological activity.
    Han YN; Kato H; Iwanaga S; Oh-Ishi S; Katori M
    J Biochem; 1978 Jan; 83(1):213-21. PubMed ID: 564343
    [No Abstract]   [Full Text] [Related]  

  • 6. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

  • 7. The kinins. A status report.
    Erdös EG
    Biochem Pharmacol; 1976 Jul; 25(14):1563-9. PubMed ID: 182170
    [No Abstract]   [Full Text] [Related]  

  • 8. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
    Chan JY; Movat HZ; Burrowes CE
    Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559
    [No Abstract]   [Full Text] [Related]  

  • 9. Formation and function of kinins.
    Eisen V
    Rheumatology; 1970; 3(0):103-68. PubMed ID: 4282177
    [No Abstract]   [Full Text] [Related]  

  • 10. Surface-mediated reactions in the formation of thrombin, plasmin and kallikrein.
    Ogston D; Bennett B
    Br Med Bull; 1978 May; 34(2):107-12. PubMed ID: 148934
    [No Abstract]   [Full Text] [Related]  

  • 11. Actions of urinary kallikrein, plasmin, and other kininogenases on bovine plasma high-molecular-weight kininogen.
    Han YN; Kato H; Iwanaga S; Komiya M
    J Biochem; 1978 Jan; 83(1):223-35. PubMed ID: 146707
    [No Abstract]   [Full Text] [Related]  

  • 12. Kininogens of human plasma.
    Habal FM; Movat HZ
    Semin Thromb Hemost; 1976 Jul; 3(1):27-42. PubMed ID: 799347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biochemistry of the kallikrein-kinin system].
    Kato H; Fujii S
    Nihon Rinsho; 1978 Aug; 36(8):2865-72. PubMed ID: 152362
    [No Abstract]   [Full Text] [Related]  

  • 14. Complexes between C1-inhibitor, kallikrein, high molecular weight kininogen, plasma thromboplastin antecedent, and plasmin in normal human plasma and hereditary angioneurotic edema plasmas containing dysmorphic C1-inhibitors: role of cold activation.
    Donaldson VH; Harrison RA
    Blood; 1982 Jul; 60(1):121-9. PubMed ID: 6211203
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced or unchanged cofactor function of human high molecular weight kininogen induced by human plasma kallikrein.
    Johansen HT; Briseid K
    Adv Exp Med Biol; 1986; 198 Pt A():147-53. PubMed ID: 3492869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood.
    Movat HZ
    Rev Physiol Biochem Pharmacol; 1978; 84():143-202. PubMed ID: 152965
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the kallikrein-kininogen-kinin system in the inflammatory reaction and septic shock].
    Hulot M; Ers P; Damas J; Adam A
    Ann Biol Clin (Paris); 1984; 42(1):35-40. PubMed ID: 6233919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions.
    Sugo T; Kato H; Iwanaga S; Takada K; Sakakibara S
    Eur J Biochem; 1985 Jan; 146(1):43-50. PubMed ID: 3871394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.
    Schapira M; Silver LD; Scott CF; Schmaier AH; Prograis LJ; Curd JG; Colman RW
    N Engl J Med; 1983 May; 308(18):1050-3. PubMed ID: 6601240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.